Senior Medical Advisor
Tore provides medical expertise in the development of clinical research programs. He has extensive experience of drug development focusing on clinical trials, safety and regulatory interactions.
He is an upper G.I. surgeon by training and was an external advisor to AstraZeneca from 1980 to 2000 where he was closely involved in the development of Losec® and Nexium®. He was also the principal investigator in numerous international clinical trials using acid suppressive therapy. He joined AstraZeneca full-time in 2000 as Global Medical Director.
Tore joined Isofol in mid-2014.